Bone Turnover Markers and Osteoprotegerin in Uncomplicated Pregnancy.
Although calcium metabolism during pregnancy is well described the mechanisms involved in bone metabolism are not quite clear. Increase of osteoprotegerin (OPG) with elevated bone turnover is supposed to be a homeostatic mechanism limiting bone loss. The aim of the study was to assess bone turnover in pregnancy in relation to serum osteoprotegerin level. Osteocalcin (OC), beta-crosslaps (CTx), OPG, vitamin 25 OH D3, parathormone (PTH), and calcium (Ca) were determined in 30 healthy women at 1(st) and at 3(rd) trimester of pregnancy and 27 healthy age-matched non pregnant women. In pregnant women average OPG, CTx and serum calcium concentrations were found to be highly elevated. During pregnancy OPG and bone resorption significantly rised whereas only slight increase in OC level was found with concomitant decrease in serum calcium. OPG correlated positively with OC and Ca only at 1(st) trimester. Serum CTx and OPG at 1(st) trimester seemed to be the only parameters to differentiate between elevated and normal bone turnover among pregnant women. In pregnancy bone turnover increases mainly due to enhanced bone resorption. The determination of osteocalcin at the beginning of pregnancy seems to be of limited clinical use, whereas measuring bone resorption markers such as CTx and/or osteoprotegerin may have a good predictive value for later pregnancy-associated bone loss.
Outpatient Rehabilitation Department, Biziel Hospital , Bydgoszcz.
Hanna
H
Styczynska
Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum , Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Kinga
K
Lis
Department of Blood Serology, Biziel Hospital , Bydgoszcz.
Izabela
I
Sobanska
Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum , Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Agnieszka
A
Pater
Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum , Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Joanna
J
Pollak
Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum , Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Aneta
A
Mankowska
bone turnover; osteoprotegerin; pregnancy
J Clin Endocrinol Metab. 2003 Nov;88(11):5361-5
14602774
J Endocrinol. 2002 Aug;174(2):353-9
12176675
J Bone Miner Res. 2000 Jan;15(1):129-37
10646122
Med Sci Monit. 2008 Dec;14(12):PH65-70
19043376
Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):506-10
17115348
J Bone Miner Res. 1996 Aug;11(8):1052-60
8854240
Osteoporos Int. 1993;3 Suppl 1:44-7
8461575
Lakartidningen. 2005 Jan 31-Feb 6;102(5):290-3
15754537
J Bone Miner Res. 2000 Mar;15(3):557-63
10750571
Obstet Gynecol Surv. 2002 Feb;57(2):99-111
11832786
Adv Med Sci. 2007;52:94-7
18217397
Z Rheumatol. 2007 Oct;66(6):510-3
17849129
Endocr Rev. 1997 Dec;18(6):832-72
9408745
J Clin Endocrinol Metab. 2002 Oct;87(10):4470-5
12364420
Cell. 2000 Sep 29;103(1):41-50
11051546
Nutrition. 2000 Nov-Dec;16(11-12):1052-5
11118824
Placenta. 2001 Sep-Oct;22(8-9):663-72
11597186
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1011-5
16157103
Ortop Traumatol Rehabil. 2004 Feb 28;6(1):123-9
17676018
Osteoporos Int. 1999;10(1):41-6
10501778
Bone. 2003 Apr;32(4):449-54
12689690
J Korean Med Sci. 2000 Apr;15(2):189-93
10803696
Osteoporos Int. 2000;11(1):1-24
10663354
Annu Rev Immunol. 2002;20:795-823
11861618
J Clin Endocrinol Metab. 2005 Nov;90(11):6323-31
16105967
J Mol Med (Berl). 2001 Jun;79(5-6):243-53
11485016